Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee ,
DOI : 10.1378/chest.101.6.1644
EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units, Intensive Care Med, vol.30, issue.4, pp.580-588, 2004. ,
Nationwide trends of severe sepsis in the 21st century, pp.1223-1254, 2000. ,
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study, Critical Care, vol.17, issue.2, p.65, 2013. ,
DOI : 10.1186/cc12598
URL : https://hal.archives-ouvertes.fr/inserm-00873494
Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge? Ann Intensive Care, p.27, 2013. ,
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.291303-291313, 2001. ,
DOI : 10.1097/00003246-200107000-00002
Profile of the Risk of Death After Septic Shock in the Present Era, Critical Care Medicine, vol.41, issue.11, 2013. ,
DOI : 10.1097/CCM.0b013e31829a6e89
Diastolic Arterial Blood Pressure: A Reliable Early Predictor of Survival in Human Septic Shock, The Journal of Trauma: Injury, Infection, and Critical Care, vol.64, issue.5, pp.1188-95, 2008. ,
DOI : 10.1097/TA.0b013e31811f3a45
High-Dose Norepinephrine Treatment: Determinants of Mortality and Futility in Critically Ill Patients, American Journal of Critical Care, vol.22, issue.1, pp.22-32 ,
DOI : 10.4037/ajcc2013748
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.341589-96, 2006. ,
DOI : 10.1097/01.CCM.0000217961.75225.E9
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis, Antimicrobial Agents and Chemotherapy, vol.54, issue.11 ,
DOI : 10.1128/AAC.00627-10
Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis, JAMA: The Journal of the American Medical Association, vol.274, issue.12, pp.274968-74, 1995. ,
DOI : 10.1001/jama.274.12.968
Drotrecogin Alfa (Activated) in Adults with Septic Shock, New England Journal of Medicine, vol.366, issue.22, pp.2055-64 ,
DOI : 10.1056/NEJMoa1202290
URL : https://hal.archives-ouvertes.fr/inserm-00865183
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis, JAMA, vol.309, issue.11, pp.3091154-62 ,
DOI : 10.1001/jama.2013.2194
Effect of norepinephrine on the outcome of septic shock, Critical Care Medicine, vol.28, issue.8, pp.2758-65, 2000. ,
DOI : 10.1097/00003246-200008000-00012
Association between vasopressor dependence and early outcome in patients after cardiac surgery, Anaesthesia, vol.20, issue.10, pp.61938-61980, 2006. ,
DOI : 10.1016/S0003-4975(03)01510-8
Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure, Critical Care Medicine, vol.28, issue.4, pp.947-956, 2000. ,
DOI : 10.1097/00003246-200004000-00006
Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study, Intensive Care Medicine, vol.32, issue.1, pp.157-62, 2008. ,
DOI : 10.1097/00003246-199811000-00016
Adjuvant Chemotherapy in Advanced Head and Neck Cancer, Oncologist, vol.2, issue.3, pp.135-176, 1997. ,
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis- Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med, issue.7, pp.22707-22717, 1996. ,
Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic, Critical Care, vol.12, issue.6, pp.12-155, 2008. ,
DOI : 10.1186/cc7149
URL : https://hal.archives-ouvertes.fr/inserm-00359832
Noradrenaline use is not associated with extubation failure in septic patients, Anaesth Intensive Care, vol.36, issue.3, pp.385-90, 2008. ,
The prevalence of nosocomial infection in intensive care 43 ,
den Hof S: Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system, Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee, pp.639-44271, 1995. ,
Increasing prevalence of antimicrobial resistance in intensive care units, Critical Care Medicine, vol.29, issue.Supplement ,
DOI : 10.1097/00003246-200104001-00002
Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting. Part II--how safe is our practice? Intensive Crit Care Nurs, pp.183-192, 2004. ,
Changeovers of vasoactive drug infusion pumps: impact of a quality improvement program Survival after shock requiring high-dose vasopressor therapy, R133. 28. Brown SM, pp.664-71, 2007. ,
Comparison of Dopamine and Norepinephrine in the Treatment of Shock, New England Journal of Medicine, vol.362, issue.9, pp.779-89, 2010. ,
DOI : 10.1056/NEJMoa0907118
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial, The Lancet, vol.370, issue.9588, pp.676-84, 2007. ,
DOI : 10.1016/S0140-6736(07)61344-0
The immunopathogenesis of sepsis, Nature, vol.288, issue.6917, pp.885-91, 2002. ,
DOI : 10.1038/nature01023
Myeloid Commitment Shifts Toward Monocytopoiesis After Thermal Injury and Sepsis, Annals of Surgery, vol.233, issue.1, pp.97-106, 2001. ,
DOI : 10.1097/00000658-200101000-00015
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421160/pdf
Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection, Apoptosis, vol.245, issue.4, pp.509-530, 2009. ,
DOI : 10.4049/jimmunol.174.8.5110
Dysregulation of the Immune Response in Severe Sepsis, The American Journal of the Medical Sciences, vol.328, issue.4, pp.220-229, 2004. ,
DOI : 10.1097/00000441-200410000-00005
Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction, Anesthesiology, vol.2012, issue.1165, pp.1083-91 ,
Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis, American Journal of Physiology-Cell Physiology, vol.287, issue.3, pp.730-736, 2004. ,
DOI : 10.1038/nm0798-808
Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis, Journal of Neuroimmunology, vol.158, issue.1-2, pp.50-57, 2005. ,
DOI : 10.1016/j.jneuroim.2004.08.003
Anti-inflammatory activity of salmeterol: down-regulation of cytokine production, Clinical & Experimental Immunology, vol.152, issue.3, pp.461-467, 1995. ,
DOI : 10.1056/NEJM198709103171102
Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?, Inflammation, vol.78, issue.1, pp.206-219 ,
DOI : 10.1093/bja/78.5.530
Stimulation of alphaadrenergic receptor augments the production of macrophage-derived tumor necrosis factor, J Immunol, vol.145, issue.5, pp.1430-1434, 1990. ,
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists, J Immunol, vol.148, issue.11, pp.3441-3446, 1992. ,
Management of Sepsis, New England Journal of Medicine, vol.355, issue.16, pp.1699-713, 2006. ,
DOI : 10.1056/NEJMra043632
Use of Heptaminol Hydrochloride for Catecholamine Weaning in Septic Shock, American Journal of Therapeutics, vol.19, issue.1, pp.8-17 ,
DOI : 10.1097/MJT.0b013e3181e9b630
Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions, Journal of Critical Care, vol.28, issue.5, pp.756-62 ,
DOI : 10.1016/j.jcrc.2013.05.021
Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery, European Journal of Anaesthesiology, vol.19, issue.11, pp.841-843, 2002. ,
DOI : 10.1017/S0265021502251352
Successful Treatment of Hypotension Associated With Stunned Myocardium with Oral Midodrine Therapy, Journal of Cardiovascular Pharmacology and Therapeutics, vol.38, issue.1, pp.77-86, 2005. ,
DOI : 10.2165/00003495-198938050-00004
Oral Midodrine Is Effective for the Treatment of Hypotension Associated With Carotid Artery Stenting, Journal of Cardiovascular Pharmacology and Therapeutics, vol.33, issue.2, pp.94-101, 2008. ,
DOI : 10.2165/00003495-198938050-00004
Midodrine: a selective ??-adrenergic agonist for orthostatic hypotension and dialysis hypotension, Expert Opinion on Pharmacotherapy, vol.44, issue.4, pp.835-875, 2000. ,
DOI : 10.1038/ki.1993.287
Midodrine, Drugs, vol.38, issue.5, pp.757-77, 1989. ,
DOI : 10.2165/00003495-198938050-00004
Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension, The American Journal of Medicine, vol.99, issue.6, pp.604-614, 1995. ,
DOI : 10.1016/S0002-9343(99)80246-0
Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers, Int Angiol, vol.12, issue.2, pp.119-143, 1993. ,
Reflexes from the heart., Physiological Reviews, vol.71, issue.3, pp.617-58, 1991. ,
DOI : 10.1152/physrev.1991.71.3.617
Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine), Neurology, vol.38, issue.6, pp.951-957, 1988. ,
DOI : 10.1212/WNL.38.6.951
Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine, The American Journal of Medicine, vol.95, issue.1, pp.38-48, 1993. ,
DOI : 10.1016/0002-9343(93)90230-M
Autonomic Insufficiency in Uremia as a Cause of Hemodialysis-Induced Hypotension, New England Journal of Medicine, vol.290, issue.12, pp.650-653, 1974. ,
DOI : 10.1056/NEJM197403212901203
Hemodialysis in Hypotensive Heart Failure Using Midodrine, The American Journal of the Medical Sciences, vol.338, issue.6, pp.470-473, 2009. ,
DOI : 10.1097/MAJ.0b013e3181b7efa7
Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure, Gastroenterology, vol.97, issue.5, pp.971304-971316, 1989. ,
DOI : 10.1016/0016-5085(89)91704-6
Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction, Hepatology, vol.17, issue.5, pp.788-93, 1993. ,
ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES*, Journal of Clinical Investigation, vol.42, issue.7, pp.421179-92, 1963. ,
DOI : 10.1172/JCI104803
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis, Hepatology, vol.116, issue.5, pp.1151-1158, 1988. ,
DOI : 10.7326/0003-4819-94-2-198
Acute effects of the oral administration of midodrine, an ?-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites, Hepatology, vol.26, issue.4, pp.937-980, 1998. ,
DOI : 10.1002/hep.510280407
What is the Role of Midodrine in Patients with Decompensated Cirrhosis?, Gastroenterol Hepatol, vol.7, issue.2, pp.134-140, 2011. ,
Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study, J Hepatol, vol.2012, issue.562, pp.348-54 ,
Uncoupling of biological oscillators, Critical Care Medicine, vol.24, issue.7, pp.1107-1123, 1996. ,
DOI : 10.1097/00003246-199607000-00008
Autonomic dysfunction in the ICU patient, Current Opinion in Critical Care, vol.7, issue.5, pp.314-336, 2001. ,
DOI : 10.1097/00075198-200110000-00002
Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome?the potential role of disease severity, Intensive Care Medicine, vol.30, issue.4, pp.665-72, 2004. ,
DOI : 10.1007/s00134-003-2131-2
Multiple organ dysfunction syndrome: Exploring the paradigm of complex nonlinear systems, Critical Care Medicine, vol.28, issue.7, pp.2193-200, 2000. ,
DOI : 10.1097/00003246-200007000-00003
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups*, Critical Care Medicine, vol.33, issue.9, pp.1994-2002, 2005. ,
DOI : 10.1097/01.CCM.0000178181.91250.99
Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.17-60, 2008. ,
DOI : 10.1097/CCM.0b013e31827e83af
A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-63, 1993. ,
DOI : 10.1001/jama.1993.03510240069035
Current Epidemiology of Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.2, pp.165-72, 2003. ,
DOI : 10.1001/jama.1996.03540110043030
Comparison of Dopamine and Norepinephrine in the Treatment of Shock, New England Journal of Medicine, vol.362, issue.9, pp.779-89, 2010. ,
DOI : 10.1056/NEJMoa0907118
Heptaminol chlorhydrate: new data, Ann Pharm Fr, vol.49, issue.3, pp.127-165, 1991. ,
Risk factors for increased mortality from hospital-acquired versus community-acquired infections in??febrile medical patients, American Journal of Infection Control, vol.37, issue.1, pp.35-42, 2009. ,
DOI : 10.1016/j.ajic.2007.11.011
Kinetics of intradialytic disequilibria: the problem, the causes, and new methods for the alleviation of patient morbidity, Nephrology Dialysis Transplantation, vol.11, issue.supp8, p.11, 1996. ,
DOI : 10.1093/ndt/11.supp8.3
Renal Failure in Cirrhosis, New England Journal of Medicine, vol.361, issue.13, pp.1279-90, 2009. ,
DOI : 10.1056/NEJMra0809139